Related Experiment Video

Updated: Aug 11, 2026

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

Different positive predictive values of commercially available human immunodeficiency virus enzyme-linked

Jesse L Clark, Thomas J Coates, Andres G Lescano

    Clinical and Vaccine Immunology : CVI
    |February 10, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
    07:10

    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

    Published on: September 14, 2014

    Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
    07:52

    Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

    Published on: September 10, 2018

    Related Experiment Videos

    Last Updated: Aug 11, 2026

    Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
    11:19

    Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

    Published on: May 4, 2015

    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
    07:10

    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

    Published on: September 14, 2014

    Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
    07:52

    Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

    Published on: September 10, 2018

    Related Concept Videos

    Enzyme-Linked Immunosorbent Assay01:33

    Enzyme-Linked Immunosorbent Assay

    In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
    There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
    Sensitivity, Specificity, and Predicted Value01:13

    Sensitivity, Specificity, and Predicted Value

    In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
    Sensitivity is the...

    Articles linked to this work by shared authors, journal, and citation graph.

    An Exploratory Study of Host Plasma Proteomic Signatures that Distinguish Secondary and Early Latent Syphilis in Adults.

    Open forum infectious diseases·2026

    Public Sentiment Toward Military Medical Research: Ethics, Cost, and Civilian Relevance.

    Military medicine·2026

    Using Tenofovir Diphosphate Levels to Evaluate Factors Associated With PrEP Non-Adherence and Performance of Indirect Adherence Measures in Latin America: A Prospective, Single-Arm, Open-Label, Multicentre Implementation Study (ImPrEP).

    Journal of the International AIDS Society·2026

    Characterization of HIV acquisitions during a large oral preexposure prophylaxis implementation study.

    AIDS (London, England)·2026

    High-throughput profiling of the IgG and IgA response to the Treponema pallidum subsp. pallidum proteome in syphilis patients.

    mBio·2026

    Zoonotic and Anthroponotic Plasmodium spp. Circulation between Wild Primates and Indigenous Community, Peruvian Amazon, 2007-2020.

    Emerging infectious diseases·2026

    The Legacy of CVI.

    Clinical and vaccine immunology : CVI·2017

    Protein Structure Facilitates High-Resolution Immunological Mapping.

    Clinical and vaccine immunology : CVI·2017

    Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a.

    Clinical and vaccine immunology : CVI·2017

    Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection.

    Clinical and vaccine immunology : CVI·2017

    High-Definition Mapping of Four Spatially Distinct Neutralizing Epitope Clusters on RiVax, a Candidate Ricin Toxin Subunit Vaccine.

    Clinical and vaccine immunology : CVI·2017

    GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.

    Clinical and vaccine immunology : CVI·2017

    [Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury].

    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition·2026

    Efficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathy.

    Frontiers in pharmacology·2026

    Gaps and disparities in Lp(a) testing before universal screening: A 10-year analysis.

    International journal of cardiology. Cardiovascular risk and prevention·2026

    Case Report: STAT3 hyper-IgE syndrome in children: two cases report with uncommon complications of tuberculosis and lymphoma.

    Frontiers in pediatrics·2026

    Elevated IGF-1 levels are associated with accelerated bone age advancement during growth hormone therapy in children: a multicenter cohort study.

    Frontiers in endocrinology·2026

    Real-world experience with IDH inhibitors in pediatric patients with IDH1- and IDH2-mutated acute myeloid leukemia and myelodysplastic syndrome.

    Haematologica·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us